Pharma Marketing Network

"Known for their athleticism, postage-stamp skirts and persuasive enthusiasm, cheerleaders have many qualities the drug industry looks for in its sales force," according to...

Despite what its own executives are saying to the FDA--i.e., unbranded DTC ads are not as effective as branded ads to drive consumers to...

AstraZeneca stunned attendees at the recent FDA hearings -- at least those "in the know" -- with an announcement that it submitted written testimony...

Join us at Strategic Research Institute's Re-Visiting Your Medicare Part D Strategy: Course Adjustment as Marketing & Enrollment Begin conference November 17 - 18, 2005 in Washington, D.C. and hear how pharmaceutical companies will need to address key stakeholders when developing and implementing their own Medicare-related strategies

Mark your calendar for this year’s event presenting solutions for identifying, profiling and communicating with KOLs from early stages of clinical trials to Post-Marketing initiatives.

The Wall Street Journal, in the article "What the In-Crowd Knows", lists Pharma Marketing Blog as a blog insiders read to stay current. Here's...

FDA's decision to block approval of OTC status for the Plan B contraceptive is rapidly becoming the center of an FDA controversy that has...

The following topics will be covered in depth in the upcoming November issue of Pharma Marketing News. Access the preview online at www.pharma-mkting.com/news/PMNissue410OnlinePreview/.DTC Pros...

This ground-breaking conference has been organized to address patient non-compliance by exploring some of the internal and external barriers that patients face when adopting a treatment plan, and by examining a number of current compliance programs in order to find the best practices for improving health outcomes.

Sales Tactics that Lead to High-End Physician Interaction and Superior Field Results